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Newborn mass screening (MS) for congenital adrenal
hyperplasia (CAH) was started in 1989 at nationwide of
Japan. To date, the goals for prevention of life-threatening
salt-wasting crises and prevention of incorrect sex assign-
ment in virilized females are almost achieved. However in
Sapporo city, which is located in the northern part of
Japan, a pilot study was started in 1982 after the assess-
ment of its feasibility and efficiency.
Here we report the results of MS from 1982 to 2010 in
Sapporo city.
In 28 years, 17-hydroxyprogesterone (17-OHP) was
determined in MS samples in 498,147 newborns and a
total of 2,466 screened newborns had abnormal 17-
OHP. Among them, 26 patients were diagnosed with
21-hydroxylase deficiency (21-OHD), which corresponds
to a prevalence of 1:19,160 live birth in Sapporo city.
It is almost identical to the worldwide incidence of CAH.
Among 26 patients, 20 patients were classified into salt-
wasting forms, 5 patients were classified into simple viriliz-
ing forms and one was classified into nonclassic forms. 19
patients were female and 7 patients were male. Two famil-
ial cases were detected. The mean examination day of 25
patients (data of one patient was not available) was 6.4
days after birth (from 0 to 18 days). Among 18 female
patients, 11 patients were clinically suspected because of
virilization prior to MS result becoming available and were
referred to neonatal center. 4 female patients were referred
after MS screening. One female patient was assigned to
male after birth; however the patient was diagnosed as
having 21-OHD by MS and the sex was changed after the
diagnosis. One female patient was a familial case and
during pregnancy prenatal treatment was done and her
genitalia was normal female. Another one patient having
normal female genitalia and no symptom, was diagnosed
as nonclassic forms by MS. By contrast to female patients,
all 7 male patients were detected by MS.
Another type of CAH was not detected in our study.
In conclusion, MS for CAH in Sapporo city can be
considered reliable.
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